Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of May 20
 +3.48 / +0.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 700.00, with a high estimate of 790.00 and a low estimate of 565.00. The median estimate represents a +5.96% increase from the last price of 660.63.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.41%
Growthannually -40.99%


Growthquarterly -5.01%
Growthannually -26.02%
Key to the earnings and sales forecast charts.